DOI:
10.1055/s-00000125
Senologie - Zeitschrift für Mammadiagnostik und -therapie
LinksClose Window
References
Patnaik A, Rosen LS, Tolaney SM et al.
LY2835219, a novel cell cycle inhibitor selective for CDK4/6, in combination with fulvestrant for patients with hormone receptor positive (HR+) metastatic breast cancer.
J Clin Oncol 2014;
32 (Suppl.) Abstract 534
We do not assume any responsibility for the contents of the web pages of other providers.